Neuromodulation and the Gut–Brain Axis: Therapeutic Mechanisms and Implications for Gastrointestinal and Neurological Disorders
Pathophysiology · 17.05.2024 · 31 (2) · 244-268
DOI: 10.3390/pathophysiology31020019 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathophysiology, online erschienen am 17.05.2024. Verfasst von Baha' Aljeradat und 10 weiteren Autor:innen. Beteiligte Einrichtung: Global Neurosurgical Alliance, Tucson, AZ 85716, USA. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The gut–brain axis (GBA) represents a complex, bidirectional communication network that intricately connects the gastrointestinal tract with the central nervous system (CNS). Understanding and intervening in this axis opens a pathway for therapeutic advancements for neurological and gastrointestinal diseases where the GBA has been proposed to play a role in the pathophysiology. In light of this, the current review assesses the effectiveness of neuromodulation techniques in treating neurological and gastrointestinal disorders by modulating the GBA, involving key elements such as gut microbiota, neurotrophic factors, and proinflammatory cytokines. Through a comprehensive literature review encompassing PubMed, Google Scholar, Web of Science, and the Cochrane Library, this research highlights the role played by the GBA in neurological and gastrointestinal diseases, in addition to the impact of neuromodulation on the management of these conditions which include both gastrointestinal (irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and gastroesophageal reflux disease (GERD)) and neurological disorders (Parkinson’s disease (PD), Alzheimer’s disease (AD), autism spectrum disorder (ASD), and neuropsychiatric disorders). Despite existing challenges, the ability of neuromodulation to adjust disrupted neural pathways, alleviate pain, and mitigate inflammation is significant in improving the quality of life for patients, thereby offering exciting prospects for future advancements in patient care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Global Neurosurgical Alliance, Tucson, AZ 85716, USA.
- School of Medicine, The University of Jordan, Amman 11942, Jordan.
- Dow Medical College, Dow University of Health Sciences, Karachi 74200, Pakistan.
- College of Health Sciences, University of Ilorin, Ilorin 240003, Kwara, Nigeria.
- Institute of Medical Sciences and SUM Hospital, Bhubaneswar 751029, India.
- Faculty of Medicine, University of Kufa, Kufa P.O. Box 21, Iraq.
ORCID-Profile: Baha' Aljeradat, Danisha Kumar, Yasser F Almealawy, Dima Ratib Batarseh, Oday Atallah
Zitieren
APA
Aljeradat, B., Kumar, D., Abdulmuizz, S., Kundu, M., Almealawy, Y. F., Batarseh, D. R., Atallah, O., Ennabe, M., Alsarafandi, M., Alan, A., & Weinand, M. (2024). Neuromodulation and the Gut–Brain Axis: Therapeutic Mechanisms and Implications for Gastrointestinal and Neurological Disorders. Pathophysiology, 31(2), 244-268. https://doi.org/10.3390/pathophysiology31020019
Vancouver
Aljeradat B, Kumar D, Abdulmuizz S, Kundu M, Almealawy YF, Batarseh DR, et al. Neuromodulation and the Gut–Brain Axis: Therapeutic Mechanisms and Implications for Gastrointestinal and Neurological Disorders. Pathophysiology. 2024;31(2):244-268. doi:10.3390/pathophysiology31020019
BibTeX
@article{Aljeradat2024,
author = {Aljeradat, Baha' and Kumar, Danisha and Abdulmuizz, Sulaiman and Kundu, Mrinmoy and Almealawy, Yasser F and Batarseh, Dima Ratib and Atallah, Oday and Ennabe, Michelle and Alsarafandi, Muath and Alan, Albert and Weinand, Martin},
title = {Neuromodulation and the Gut–Brain Axis: Therapeutic Mechanisms and Implications for Gastrointestinal and Neurological Disorders},
journal = {Pathophysiology},
year = {2024},
volume = {31},
number = {2},
pages = {244--268},
doi = {10.3390/pathophysiology31020019}
}
EUVIMED